✦ LIBER ✦

Association between in Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer Patients

✍ Scribed by Robert W. Holloway; Rita S. Mehta; Neil J. Finkler; Kuo-Tung Li; Christine E. McLaren; Ricardo J. Parker; John P. Fruehauf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro extreme drug resistance assay t

✍ Hee Seung Kim; Tae Joong Kim; Hyun Hoon Chung; Jae Weon Kim; Byung Gie Kim; Noh 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 308 KB

In vitro extreme drug resistance assay t

✍ Hee Seung Kim; Tae Joong Kim; Hyun Hoon Chung; Jae Weon Kim; Byung Gie Kim; Noh 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 308 KB

In vitro drug testing of ovarian cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 142 KB

In Vitro Drug Testing of Ovarian Cancer

✍ Massimo Federico; David S. Alberts; Dava J. Garcia; Julia Emerson; Paul Fanta; R 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Association between neoadjuvant chemothe

✍ E. Tanner; K. Long; N. Lakhi; G. Gardner; M. Leitao; Y. Sonoda; N. Abu-Rustum; D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

CON: Therapy for a Patient with Platinum

✍ John Farley; Michael J. Birrer 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 342 KB